Last reviewed · How we verify
NCT06377345
Remote Patient Monitoring Solution for Chronic Respiratory Disease Management
NA trial testing AeviceMD device in Asthma in 180 participants. Currently enrolling.
30 September 2025
Quick facts
| Lead sponsor | SingHealth Polyclinics |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 180 |
| Start date | 1 May 2024 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- AeviceMD device
- Standard care — full drug profile →
Conditions studied
- Asthma — all drugs for Asthma →
- Asthma Attack — all drugs for Asthma Attack →
- Asthma in Children — all drugs for Asthma in Children →
- Asthma Acute — all drugs for Asthma Acute →
Sponsor
SingHealth Polyclinics
Who can join
Adults 7 to 90, any sex, with Asthma or Asthma Attack. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim: To evaluate the use of AeviceMD Monitoring System (AeviceMD) asthma in reducing acute exacerbation. Methodology: Using a randomized controlled trial design, this project aims evaluate the effectiveness of AeviceMD in improving patients' outcomes in terms of reducing exacerbation, healthcare utilization, improving quality of life, self-efficacy, and cost effectiveness. Paediatric patients above age 7 and adults will be recruited. The data follow-up period is 3 months. It will also evaluate the usability of the device from both patients' and clinicians' perspective. 180 patients (124 adults, 56 pediatrics) and 120 clinicians will be recruited. Importance of study: This study will evaluate if the AeviceMD can help improve disease management and reduce recurrence of asthma exacerbation. Potential benefits and risk: AeviceMD allows for remote monitoring and tracking of patients' lung sounds, which could be used by patients to monitor their lung condition and prevent an episode of exacerbation or worsening exacerbations culminating in an admission which who further utilize already limited healthcare resources. An exacerbation is an episode of severe shortness of breath, cough, and chest tightening which warrants a visit to a healthcare institution. Through self-monitoring, patients can be empowered to self-manage their asthma, with aid of the asthma action plan which is given to all patients with asthma. AeviceMD can also help provide clinicians with patients' objective lung data. In the primary care setting, care is also fragmented as patients are often followed-up by a different doctor or healthcare providers. Clinicians have no objective data to track patients, and is dependent on patients' self-report and possible recall bias. There is no expected risk with the use of the device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06377345
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other SingHealth Polyclinics trials
Trials by the same sponsor.
- NCT07399912 — Engaging Home-monitored Assessment to Navigate Clinical Decision-making · NA · enrolling by invitation
- NCT07004231 — Using Gout Buddy to Enhance Gout Management · NA · not yet recruiting
- NCT06607497 — Better Risk Perception Via Patient Similarity to Control Hyperglycemia and Sustained by Telemonitoring · NA · active not recruiting
- NCT06205303 — Interventional Study to Improve Medication Adherence Using Patient Decision Aid · NA · recruiting
- NCT06837428 — Peer Comparison-based Risk Communication · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06377345 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SingHealth Polyclinics
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06377345.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing